Cancer

Germany’s BioNTech buys China’s Biotheus in US$800 million push into cancer drugs – Go Health Pro

by
Germany’s BioNTech buys China’s Biotheus in US0 million push into cancer drugs – Go Health Pro

BioNTech, the German developer of a widely used mRNA vaccine for the coronavirus, agreed to pay US$800 million (HK$6.24 billion) to buy biotech company Biotheus, a developer of cancer drugs. In a statement on Wednesday, Mainz-based BioNTech said it signed a definitive agreement to pay mostly cash for 100 per cent of Biotheus, which is … Read more

Zacks Small Cap Analysis – VNRX: Nu.Q Vet Check is now obtainable in 17 international locations. Value slicing continues in a plan to be money move impartial in 2025. Administration centered on signing licensing offers for Seize-PCR (human most cancers detection technique) and Nu.Q NET for sepsis. $7.0 million financing accomplished. – Go Well being Professional

by
Zacks Small Cap Analysis – VNRX: Nu.Q Vet Check is now obtainable in 17 international locations. Value slicing continues in a plan to be money move impartial in 2025. Administration centered on signing licensing offers for Seize-PCR (human most cancers detection technique) and Nu.Q NET for sepsis. .0 million financing accomplished. – Go Well being Professional

By Steven Ralston, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT SIGNIFICANT OPERATIONAL UPDATES Administration is implementing a important value slicing program with the aim of making certain that Volition (NYSE:VNRX) is money move impartial in 2025. Value reductions taken throughout 1H 2024 resulted in a 15.9% decline in working bills. Value discount measures have … Read more

x